BioCentury
ARTICLE | Clinical News

Ad-RTS-hIL-12: Preliminary Ph Ib/II data

December 1, 2016 11:39 AM UTC

Preliminary data from 9 evaluable patients with locally advanced or metastatic breast cancer in an open-label, U.S. Phase Ib/II trial showed that 1x1012 viral particles per injection of intratumoral A...

BCIQ Target Profiles

Interleukin-12 (IL-12)